Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Emily D. Parker, PhD, MPH
Advertisement
Articles by Emily D. Parker, PhD, MPH
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Physician practices account for a significant amount of variation in spending.
Advertisement
Latest Updated Articles
- Variation in Spending Associated With Primary Care Practices
December 15th 2020
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
4
Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
5